Clinical Trial Update: Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update describes the effect of prophylactic tyrosine kinase inhibitor therapy after allogeneic stem cell transplantation in Philadelphia chromo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphocytic Leukemia

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Philadelphia Chromosome Positive Acute Lymphocytic Leukemia, Tyrosine Kinase Inhibitor | Phase 2, Phase 3 | Status: UNKNOWN